Provention Bio Inc (PRVB)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

P.O. BOX 666 OLDWICK, NJ 08858

Provention Bio, Inc. operates as a biopharmaceutical company. The Company focuses on development of novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease. Provention Bio serves patients in the State of New Jersey.

Data based on most recent fiscal year report
Market Cap845.61 Million Shares Outstanding47.64 Million Avg Volume639.994 Thousand
1-Yr BETA vs S&P TR1.45 Current Ratio32.9 Quick Ratio32.9
View SEC Filings from PRVB instead.

View recent insider trading info

Funds Holding PRVB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PRVB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

14.5 Thousand total shares from 2 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LEON FRANCISCO CHIEF SCIENTIFIC OFFICER

  • Officer
2,563,450 2020-03-19 5

HOITT JASON CHIEF COMMERCIAL OFFICER

  • Officer
4,500 2020-03-19 3

DIGIANDOMENICO ANTHONY

  • Director
0 2020-01-02 9

GRAY CAMERON

  • Director
0 2020-01-02 0

RAMOS ELEANOR CMO & COO

  • Officer
62,000 2019-12-26 2

PALMER ASHLEIGH PRESIDENT AND CEO

  • Officer
  • Director
2,563,000 2019-12-20 5

DOHERTY SEAN M

  • Director
0 2019-09-26 2

DRECHSLER ANDREW T CHIEF FINANCIAL OFFICER

  • Officer
0 2019-06-24 1

PISANO WAYNE

  • Director
0 2019-06-24 1

CATLIN AVERY W

  • Director
0 2019-06-24 1

BLUESTONE JEFFREY

  • Director
0 2019-06-24 2

CATLIN AVERY W

CATLIN AVERY W

  • Director
0 2018-09-05 1

MDB CAPITAL GROUP LLC

  • 10% Owner
No longer subject to file 2018-07-19 0

JOHNSON & JOHNSON

JOHNSON & JOHNSON INNOVATION - JJDC, INC.

  • 10% Owner
No longer subject to file 2018-07-19 0

VACTECH OY

  • 10% Owner
No longer subject to file 2018-07-19 0

APPEL PETER A

  • 10% Owner
No longer subject to file 2018-07-19 0

MACROGENICS INC

  • 10% Owner
0 2018-07-03 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

LEON FRANCISCO - Officer CHIEF SCIENTIFIC OFFICER

2020-03-19 P 10,000 $5.92 a 2,563,450 2,563,450.00 direct

HOITT JASON - Officer CHIEF COMMERCIAL OFFICER

2020-03-19 P 4,500 $5.43 a 4,500 4,500.00 direct

Elevate your investments